Gary Patou is of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 23,573 shares of XENE, which is worth approximately $911,096. The most recent transaction as insider was on Dec 13, 2023, when has been sold 11,380 shares (Common Shares) at a price of $39.29 per share, resulting in proceeds of $447,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.6K
0% 3M change
0% 12M change
Total Value Held $911,096

GARY PATOU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2023
SELL
Open market or private sale
$447,120 $39.29 p/Share
11,380 Reduced 32.56%
23,573 Common Shares
Dec 13 2023
SELL
Payment of exercise price or tax liability
$119,912 $39.68 p/Share
3,022 Reduced 9.88%
27,550 Common Shares
Dec 13 2023
BUY
Exercise of conversion of derivative security
$137,827 $9.57 p/Share
14,402 Added 33.4%
28,717 Common Shares
Nov 25 2022
SELL
Open market or private sale
$67,388 $34.79 p/Share
1,937 Reduced 7.59%
23,573 Common Shares
Nov 25 2022
SELL
Payment of exercise price or tax liability
$4,124 $34.37 p/Share
120 Reduced 0.47%
25,510 Common Shares
Nov 25 2022
BUY
Exercise of conversion of derivative security
$5,512 $2.68 p/Share
2,057 Added 7.43%
25,630 Common Shares
Nov 23 2022
SELL
Open market or private sale
$70,616 $34.33 p/Share
2,057 Reduced 8.03%
23,573 Common Shares
Dec 08 2021
BUY
Exercise of conversion of derivative security
$7,549 $3.67 p/Share
2,057 Added 7.43%
25,630 Common Shares
Oct 28 2020
BUY
Exercise of conversion of derivative security
$7,734 $3.76 p/Share
2,057 Added 8.03%
23,573 Common Shares
GP

Gary Patou

Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Track Activities on XENE